aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Kearny Venture Partners is a healthcare-focused investment firm specializing in emerging healthcare products. The firm primarily invests in Series B, C, and post-IPO equity rounds, with occasional participation in Series A and D rounds. Their geographical focus appears to be the United States, targeting companies with significant market potential in areas of unmet medical needs.
Notable portfolio companies include Akebia Therapeutics, Cvrx, and ViewRay. Kearny Venture Partners believes in the power of innovative solutions in medicine and seeks to support entrepreneurs developing safe and effective products. The firm's investment philosophy centers on leveraging the increasing understanding of disease mechanisms to identify novel intervention opportunities in healthcare.
Also Known As
Kearny Venture Capital, L.L.C.
Operating Status
Active
Kearny Venture Partners Address
San Francisco,
California
94111
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts